The latest from Amide
Every peptide drug design program eventually hits the same fork: the linear sequence won’t get you the potency, stability, or selectivity you...
Introduction There is a particular kind of frustration that runs through modern peptide drug discovery programs, one that does not show up cleanly...
Vaccine science has been quietly undergoing a structural revolution. Not in the delivery mechanisms or the adjuvants, but in the molecular architecture...
Amide is accepting customers looking for a reliable source for hard-to-obtain peptides.